Annual Interest Expense
$50.15 M
+$13.03 M+35.10%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual interest expense is $50.15 million, with the most recent change of +$13.03 million (+35.10%) on December 31, 2023.
- During the last 3 years, FOLD annual interest expense has risen by +$27.72 million (+123.63%).
- FOLD annual interest expense is now at all-time high.
Performance
FOLD Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$12.69 M
+$180.00 K+1.44%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly interest expense is $12.69 million, with the most recent change of +$180.00 thousand (+1.44%) on September 30, 2024.
- Over the past year, FOLD quarterly interest expense has dropped by -$294.00 thousand (-2.26%).
- FOLD quarterly interest expense is now -2.26% below its all-time high of $12.99 million, reached on September 30, 2023.
Performance
FOLD Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$50.47 M
-$294.00 K-0.58%
September 30, 2024
Summary
- As of February 7, 2025, FOLD TTM interest expense is $50.47 million, with the most recent change of -$294.00 thousand (-0.58%) on September 30, 2024.
- Over the past year, FOLD TTM interest expense has increased by +$2.05 million (+4.23%).
- FOLD TTM interest expense is now -0.58% below its all-time high of $50.76 million, reached on June 30, 2024.
Performance
FOLD TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
FOLD Interest Expense Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +35.1% | -2.3% | +4.2% |
3 y3 years | +123.6% | -2.3% | +4.2% |
5 y5 years | +123.9% | -2.3% | +4.2% |
FOLD Interest Expense Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +54.4% | -2.3% | +55.8% | -0.6% | +55.4% |
5 y | 5-year | at high | +165.7% | -2.3% | +249.2% | -0.6% | +233.0% |
alltime | all time | at high | >+9999.0% | -2.3% | >+9999.0% | -0.6% | >+9999.0% |
Amicus Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $12.69 M(+1.4%) | $50.47 M(-0.6%) |
Jun 2024 | - | $12.51 M(+0.6%) | $50.76 M(+0.0%) |
Mar 2024 | - | $12.44 M(-3.0%) | $50.74 M(+1.2%) |
Dec 2023 | $50.15 M(+35.1%) | $12.83 M(-1.2%) | $50.15 M(+3.6%) |
Sep 2023 | - | $12.99 M(+4.0%) | $48.42 M(+7.5%) |
Jun 2023 | - | $12.49 M(+5.5%) | $45.05 M(+10.4%) |
Mar 2023 | - | $11.84 M(+6.8%) | $40.82 M(+10.0%) |
Dec 2022 | $37.12 M(+14.3%) | $11.10 M(+15.3%) | $37.12 M(+8.6%) |
Sep 2022 | - | $9.62 M(+16.5%) | $34.19 M(+4.4%) |
Jun 2022 | - | $8.26 M(+1.4%) | $32.73 M(+0.3%) |
Mar 2022 | - | $8.15 M(-0.2%) | $32.63 M(+0.5%) |
Dec 2021 | $32.47 M(+44.8%) | $8.16 M(-0.0%) | $32.47 M(-0.3%) |
Sep 2021 | - | $8.16 M(+0.2%) | $32.58 M(+4.4%) |
Jun 2021 | - | $8.15 M(+2.0%) | $31.20 M(+16.9%) |
Mar 2021 | - | $7.99 M(-3.4%) | $26.69 M(+19.0%) |
Dec 2020 | $22.43 M(+18.8%) | $8.28 M(+22.0%) | $22.43 M(+25.2%) |
Sep 2020 | - | $6.78 M(+86.6%) | $17.91 M(+18.2%) |
Jun 2020 | - | $3.63 M(-2.5%) | $15.16 M(-6.1%) |
Mar 2020 | - | $3.73 M(-1.0%) | $16.15 M(-14.4%) |
Dec 2019 | $18.87 M(-15.8%) | $3.77 M(-6.4%) | $18.87 M(-20.5%) |
Sep 2019 | - | $4.03 M(-13.0%) | $23.74 M(-2.8%) |
Jun 2019 | - | $4.63 M(-28.3%) | $24.43 M(+0.3%) |
Mar 2019 | - | $6.45 M(-25.3%) | $24.37 M(+8.8%) |
Dec 2018 | $22.40 M(+29.9%) | $8.64 M(+83.2%) | $22.40 M(+23.2%) |
Sep 2018 | - | $4.71 M(+3.4%) | $18.18 M(+2.0%) |
Jun 2018 | - | $4.56 M(+1.6%) | $17.82 M(+2.2%) |
Mar 2018 | - | $4.49 M(+1.5%) | $17.44 M(+1.1%) |
Dec 2017 | $17.24 M(+219.4%) | $4.42 M(+1.6%) | $17.24 M(+17.3%) |
Sep 2017 | - | $4.35 M(+4.1%) | $14.70 M(+23.9%) |
Jun 2017 | - | $4.18 M(-2.6%) | $11.87 M(+35.7%) |
Mar 2017 | - | $4.29 M(+128.1%) | $8.74 M(+62.0%) |
Dec 2016 | $5.40 M | $1.88 M(+24.0%) | $5.40 M(+23.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | $1.52 M(+43.8%) | $4.37 M(+52.3%) |
Jun 2016 | - | $1.05 M(+11.6%) | $2.87 M(+33.3%) |
Mar 2016 | - | $945.00 K(+11.0%) | $2.15 M(+36.3%) |
Dec 2015 | $1.58 M(+6.3%) | $851.00 K(+4905.9%) | $1.58 M(+42.8%) |
Sep 2015 | - | $17.00 K(-95.0%) | $1.10 M(-24.6%) |
Jun 2015 | - | $338.00 K(-9.1%) | $1.47 M(-2.4%) |
Mar 2015 | - | $372.00 K(-1.6%) | $1.50 M(+1.1%) |
Dec 2014 | $1.48 M(+3126.1%) | $378.00 K(+0.3%) | $1.48 M(+31.8%) |
Sep 2014 | - | $377.00 K(+0.8%) | $1.13 M(+48.9%) |
Jun 2014 | - | $374.00 K(+5.4%) | $756.00 K(+93.4%) |
Mar 2014 | - | $355.00 K(+1675.0%) | $391.00 K(+750.0%) |
Dec 2013 | $46.00 K(-48.3%) | $20.00 K(+185.7%) | $46.00 K(+21.1%) |
Sep 2013 | - | $7000.00(-22.2%) | $38.00 K(-24.0%) |
Jun 2013 | - | $9000.00(-10.0%) | $50.00 K(-10.7%) |
Mar 2013 | - | $10.00 K(-16.7%) | $56.00 K(-37.1%) |
Dec 2012 | $89.00 K(-39.9%) | $12.00 K(-36.8%) | $89.00 K(-14.4%) |
Sep 2012 | - | $19.00 K(+26.7%) | $104.00 K(-11.1%) |
Jun 2012 | - | $15.00 K(-65.1%) | $117.00 K(-18.2%) |
Mar 2012 | - | $43.00 K(+59.3%) | $143.00 K(-3.4%) |
Dec 2011 | $148.00 K(-43.1%) | $27.00 K(-15.6%) | $148.00 K(-16.9%) |
Sep 2011 | - | $32.00 K(-22.0%) | $178.00 K(-16.0%) |
Jun 2011 | - | $41.00 K(-14.6%) | $212.00 K(-6.2%) |
Mar 2011 | - | $48.00 K(-15.8%) | $226.00 K(-13.4%) |
Dec 2010 | $260.00 K(-6.5%) | $57.00 K(-13.6%) | $261.00 K(-20.2%) |
Sep 2010 | - | $66.00 K(+20.0%) | $327.00 K(-5.2%) |
Jun 2010 | - | $55.00 K(-33.7%) | $345.00 K(+4.2%) |
Mar 2010 | - | $83.00 K(-32.5%) | $331.00 K(+19.5%) |
Dec 2009 | $278.00 K(+27.5%) | $123.00 K(+46.4%) | $277.00 K(+79.9%) |
Sep 2009 | - | $84.00 K(+104.9%) | $154.00 K(+120.0%) |
Jun 2009 | - | $41.00 K(+41.4%) | $70.00 K(+141.4%) |
Mar 2009 | - | $29.00 K | $29.00 K |
Dec 2008 | $218.00 K | - | - |
FAQ
- What is Amicus Therapeutics annual interest expense?
- What is the all time high annual interest expense for Amicus Therapeutics?
- What is Amicus Therapeutics annual interest expense year-on-year change?
- What is Amicus Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly interest expense year-on-year change?
- What is Amicus Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Amicus Therapeutics?
- What is Amicus Therapeutics TTM interest expense year-on-year change?
What is Amicus Therapeutics annual interest expense?
The current annual interest expense of FOLD is $50.15 M
What is the all time high annual interest expense for Amicus Therapeutics?
Amicus Therapeutics all-time high annual interest expense is $50.15 M
What is Amicus Therapeutics annual interest expense year-on-year change?
Over the past year, FOLD annual interest expense has changed by +$13.03 M (+35.10%)
What is Amicus Therapeutics quarterly interest expense?
The current quarterly interest expense of FOLD is $12.69 M
What is the all time high quarterly interest expense for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly interest expense is $12.99 M
What is Amicus Therapeutics quarterly interest expense year-on-year change?
Over the past year, FOLD quarterly interest expense has changed by -$294.00 K (-2.26%)
What is Amicus Therapeutics TTM interest expense?
The current TTM interest expense of FOLD is $50.47 M
What is the all time high TTM interest expense for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM interest expense is $50.76 M
What is Amicus Therapeutics TTM interest expense year-on-year change?
Over the past year, FOLD TTM interest expense has changed by +$2.05 M (+4.23%)